Strengths and limitations of using ¹⁸fluorine-fluorodihydroxyphenylalanine PET/CT for congenital hyperinsulinism

References

• Glaser B, Thornton P, Otonkoski T, Junien C. Genetics of neonatal hyperinsulinism. Arch Dis Child Fetal Neonatal Ed 2000;82(2):F79-86
   Google Scholar
• de Lonlay P, Fournet JC, Rahier J, et al. Somatic deletion of the imprinted 11p15 region in sporadic persistent hyperinsulinemic hypoglycemia of infancy is specific of focal adenomatous hyperplasia and endorses partial pancreatectomy. J Clin Invest 1997;100(4):802-7
   Google Scholar
• Kapoor RR, Flanagan SE, James C, et al. Hyperinsulinaemic hypoglycaemia. Arch Dis Child 2009;94(6):450-7
   PubMed Web of Science ®Google Scholar
• Cretolle C, Fekete CN, Jan D, et al. Partial elective pancreatectomy is curative in focal form of permanent hyperinsulinemic hypoglycaemia in infancy: a report of 45 cases from 1983 to 2000. J Pediatr Surg 2002;37(2):155-8
   Web of Science ®Google Scholar
• Rahier J, Guiot Y, Sempoux C. Morphologic analysis of focal and diffuse forms of congenital hyperinsulinism. Semin Pediatr Surg 2011;20(1):3-12
   Web of Science ®Google Scholar
• Zani A, Nah SA, Ron O, et al. The predictive value of preoperative fluorine-18-L-3,4-dihydroxyphenylalanine positron emission tomography-computed tomography scans in children with congenital hyperinsulinism of infancy. J Pediatr Surg 2011;46(1):204-8
   Google Scholar
• Brunelle F, Negre V, Barth MO, et al. Pancreatic venous samplings in infants and children with primary hyperinsulinism. Pediatr Radiol 1989;19(2):100-3
   Google Scholar
• Chigot V, De Lonlay P, Nassogne MC, et al. Pancreatic arterial calcium stimulation in the diagnosis and localisation of persistent hyperinsulinemic hypoglycaemia of infancy. Pediatr Radiol 2001;31(9):650-5
   Google Scholar
• Stanley CA, Thornton PS, Ganguly A, et al. Preoperative evaluation of infants with focal or diffuse congenital hyperinsulinism by intravenous acute insulin response tests and selective pancreatic arterial calcium stimulation. J Clin Endocrinol Metab 2004;89(1):288-96
   Web of Science ®Google Scholar
• Balogova S, Talbot JN, Nataf V, et al. 18F-fluorodihydroxyphenylalanine vs other radiopharmaceuticals for imaging neuroendocrine tumours according to their type. Eur J Nucl Med Mol Imaging 2013;40(6):943-66
   Google Scholar
• Guettier JM, Gorden P. Insulin secretion and insulin-producing tumors. Expert Rev Endocrinol Metab 2010;5(2):217-27
   PubMedGoogle Scholar
• Rahier J, Falt K, Muntefering H, et al. The basic structural lesion of persistent neonatal hypoglycaemia with hyperinsulinism: deficiency of pancreatic D cells or hyperactivity of B cells? Diabetologia 1984;26(4):282-9
   Google Scholar
• Sempoux C, Guiot Y, Dahan K, et al. The focal form of persistent hyperinsulinemic hypoglycemia of infancy: morphological and molecular studies show structural and functional differences with insulinoma. Diabetes 2003;52(3):784-94
   Web of Science ®Google Scholar
• Rahier J, Sempoux C, Fournet JC, et al. Partial or near-total pancreatectomy for persistent neonatal hyperinsulinaemic hypoglycaemia: the pathologist’s role. Histopathology 1998;32(1):15-19
   Google Scholar
• Khen-Dunlop N, Capito C, Valayannopoulos V, et al. Predictive value of postoperative glycosuria after partial elective pancreatectomy in focal congenital hyperinsulinism. Diabetes Care 2008;31(10):e71
   Google Scholar
• Ericson LE, Hakanson R, Lundquist I. Accumulation of dopamine in mouse pancreatic B-cells following injection of L-DOPA. Localization to secretory granules and inhibition of insulin secretion. Diabetologia 1977;13(2):117-24
   PubMed Web of Science ®Google Scholar
• Barthlen W, de Lonlay P. Congenital hyperinsulinism. Semin Pediatr Surg 2011;20(1):1-2
   Google Scholar
• Kauhanen S, Seppanen M, Minn H, Nuutila P. Clinical PET imaging of insulinoma and beta-cell hyperplasia. Curr Pharm Des 2010;16(14):1550-60
   Google Scholar
• de Lonlay P, Simon-Carre A, Ribeiro MJ, et al. Congenital hyperinsulinism: pancreatic [18F]fluoro-L-dihydroxyphenylalanine (DOPA) positron emission tomography and immunohistochemistry study of DOPA decarboxylase and insulin secretion. J Clin Endocrinol Metab 2006;91(3):933-40
   Google Scholar
• Borelli MI, Villar MJ, Orezzoli A, Gagliardino JJ. Presence of DOPA decarboxylase and its localisation in adult rat pancreatic islet cells. Diabetes Metab 1997;23(2):161-3
   Google Scholar
• Mohnike K, Blankenstein O, Christesen HT, et al. Proposal for a standardized protocol for 18F-DOPA-PET (PET/CT) in congenital hyperinsulinism. Horm Res 2006;66(1):40-2
   Google Scholar
• Gazdar AF, Helman LJ, Israel MA, et al. Expression of neuroendocrine cell markers L-dopa decarboxylase, chromogranin A, and dense core granules in human tumors of endocrine and nonendocrine origin. Cancer Res 1988;48(14):4078-82
   Google Scholar
• Arnoux JB, de Lonlay P, Ribeiro MJ, et al. Congenital hyperinsulinism. Early Hum Dev 2010;86(5):287-94
   Google Scholar
• Arnoux JB, Verkarre V, Saint-Martin C, et al. Congenital hyperinsulinism: current trends in diagnosis and therapy. Orphanet J Rare Dis 2011;6:63
   PubMed Web of Science ®Google Scholar
• Snider KE, Becker S, Boyajian L, et al. Genotype and phenotype correlations in 417 children with congenital hyperinsulinism. J Clin Endocrinol Metab 2013;98(2):E355-63
   Web of Science ®Google Scholar
• Banerjee I, Avatapalle B, Padidela R, et al. Integrating genetic and imaging investigations into the clinical management of congenital hyperinsulinism. Clin Endocrinol (Oxf) 2013;78(6):803-13
   Google Scholar
• Ribeiro MJ, De Lonlay P, Delzescaux T, et al. Characterization of hyperinsulinism in infancy assessed with PET and 18F-fluoro-L-DOPA. J Nucl Med 2005;46(4):560-6
   PubMed Web of Science ®Google Scholar
• Ribeiro MJ, Boddaert N, Bellanne-Chantelot C, et al. The added value of [18F]fluoro-L-DOPA PET in the diagnosis of hyperinsulinism of infancy: a retrospective study involving 49 children. Eur J Nucl Med Mol Imaging 2007;34(12):2120-8
   Google Scholar
• Otonkoski T, Nanto-Salonen K, Seppanen M, et al. Noninvasive diagnosis of focal hyperinsulinism of infancy with [18F]-DOPA positron emission tomography. Diabetes 2006;55(1):13-18
   PubMed Web of Science ®Google Scholar
• Hardy OT, Hernandez-Pampaloni M, Saffer JR, et al. Accuracy of [18F]fluorodopa positron emission tomography for diagnosing and localizing focal congenital hyperinsulinism. J Clin Endocrinol Metab 2007;92(12):4706-11
   Google Scholar
• Alessio AM, Kinahan PE, Manchanda V, et al. Weight-based, low-dose pediatric whole-body PET/CT protocols. J Nucl Med 2009;50(10):1570-7
   Google Scholar
• Brenner D, Elliston C, Hall E, Berdon W. Estimated risks of radiation-induced fatal cancer from pediatric CT. AJR Am J Roentgenol 2001;176(2):289-96
   PubMed Web of Science ®Google Scholar
• Blomberg BA, Moghbel MC, Saboury B, et al. The value of radiologic interventions and (18)F-DOPA PET in diagnosing and localizing focal congenital hyperinsulinism: systematic review and meta-analysis. Mol Imaging Biol 2013;15(1):97-105
   Google Scholar
• Connolly B, Racadio J, Towbin R. Practice of ALARA in the pediatric interventional suite. Pediatr Radiol 2006;36(Suppl 2):163-7
   Google Scholar
• Lopci E, D’Ambrosio D, Nanni C, et al. Feasibility of carbidopa premedication in pediatric patients: a pilot study. Cancer Biother Radiopharm 2012;27(10):729-33
   Google Scholar
• Kauhanen S, Seppanen M, Ovaska J, et al. The clinical value of [18F]fluoro-dihydroxyphenylalanine positron emission tomography in primary diagnosis, staging, and restaging of neuroendocrine tumors. Endocr Relat Cancer 2009;16(1):255-65
   Google Scholar
• Kauhanen S, Seppanen M, Nuutila P. Premedication with carbidopa masks positive finding of insulinoma and beta-cell hyperplasia in [(18)F]-dihydroxy-phenyl-alanine positron emission tomography. J Clin Oncol 2008;26(32):5307-8. author reply 8-9
   Google Scholar
• Treglia G, Mirk P, Giordano A, Rufini V. Diagnostic performance of fluorine-18-dihydroxyphenylalanine positron emission tomography in diagnosing and localizing the focal form of congenital hyperinsulinism: a meta-analysis. Pediatr Radiol 2012;42(11):1372-9
   Google Scholar
• Ismail D, Kapoor RR, Smith VV, et al. The heterogeneity of focal forms of congenital hyperinsulinism. J Clin Endocrinol Metab 2012;97(1):E94-9
   Google Scholar
• Laje P, States LJ, Zhuang H, et al. Accuracy of PET/CT Scan in the diagnosis of the focal form of congenital hyperinsulinism. J Pediatr Surg 2013;48(2):388-93
   Web of Science ®Google Scholar
• Kapoor RR, Gilbert C, Mohnike K, et al. Congenital hyperinsulinism: [F]DOPA PET/CT scan of a focal lesion in the head of the pancreas. BMJ Case Rep 2009;2009:bcr2007121178
   Google Scholar
• Giurgea I, Sempoux C, Bellanne-Chantelot C, et al. The Knudson’s two-hit model and timing of somatic mutation may account for the phenotypic diversity of focal congenital hyperinsulinism. J Clin Endocrinol Metab 2006;91(10):4118-23
   Web of Science ®Google Scholar
• Hussain K, Seppanen M, Nanto-Salonen K, et al. The diagnosis of ectopic focal hyperinsulinism of infancy with [18F]-dopa positron emission tomography. J Clin Endocrinol Metab 2006;91(8):2839-42
   Google Scholar
• Peranteau WH, Bathaii SM, Pawel B, et al. Multiple ectopic lesions of focal islet adenomatosis identified by positron emission tomography scan in an infant with congenital hyperinsulinism. J Pediatr Surg 2007;42(1):188-92
   Web of Science ®Google Scholar
• Yorifuji T, Hosokawa Y, Fujimaru R, et al. Lasting 18F-DOPA PET uptake after clinical remission of the focal form of congenital hyperinsulinism. Horm Res Paediatr 2011;76(4):286-90
   Google Scholar
• Arifin DR, Bulte JW. Imaging of pancreatic islet cells. Diabetes Metab Res Rev 2011;27(8):761-6
   Google Scholar
• Rufini V, Baum RP, Castaldi P, et al. Role of PET/CT in the functional imaging of endocrine pancreatic tumors. Abdom Imaging 2012;37(6):1004-20
   PubMedGoogle Scholar
• Selvaraju RK, Velikyan I, Johansson L, et al. In vivo imaging of the glucagonlike peptide 1 receptor in the pancreas with 68Ga-labeled DO3A-exendin-4. J Nucl Med 2013;54(8):1458-63
   Google Scholar
• Reubi JC, Waser B. Concomitant expression of several peptide receptors in neuroendocrine tumours: molecular basis for in vivo multireceptor tumour targeting. Eur J Nucl Med Mol Imaging 2003;30(5):781-93
   PubMed Web of Science ®Google Scholar
• Korner M, Stockli M, Waser B, Reubi JC. GLP-1 receptor expression in human tumors and human normal tissues: potential for in vivo targeting. J Nucl Med 2007;48(5):736-43
   PubMed Web of Science ®Google Scholar
• Wild D, Macke H, Christ E, et al. Glucagon-like peptide 1-receptor scans to localize occult insulinomas. N Engl J Med 2008;359(7):766-8
   PubMed Web of Science ®Google Scholar
• Eriksson O, Velikyan I, Selvaraju RK, et al. Detection of metastatic insulinoma by positron emission tomography with [Ga]Exendin-4 - a case report. J Clin Endocrinol Metab 2014;99(5):1519-24
   Google Scholar
• De Leon DD, Li C, Delson MI, et al. Exendin-(9-39) corrects fasting hypoglycemia in SUR-1-/- mice by lowering cAMP in pancreatic beta-cells and inhibiting insulin secretion. J Biol Chem 2008;283(38):25786-93
   Google Scholar
• Calabria AC, Li C, Gallagher PR, et al. GLP-1 receptor antagonist exendin-(9-39) elevates fasting blood glucose levels in congenital hyperinsulinism owing to inactivating mutations in the ATP-sensitive K+ channel. Diabetes 2012;61(10):2585-91
   Google Scholar
• Normandin MD, Petersen KF, Ding YS, et al. In vivo imaging of endogenous pancreatic beta-cell mass in healthy and type 1 diabetic subjects using 18F-fluoropropyl-dihydrotetrabenazine and PET. J Nucl Med 2012;53(6):908-16
   PubMedGoogle Scholar
• Harris PE, Leibel RL. Neurofunctional imaging of beta-cell dynamics. Diabetes Obes Metab 2012;14(Suppl 3):91-100
   Google Scholar
• Fagerholm V, Mikkola KK, Ishizu T, et al. Assessment of islet specificity of dihydrotetrabenazine radiotracer binding in rat pancreas and human pancreas. J Nucl Med 2010;51(9):1439-46
   Google Scholar
• Ichise M, Harris PE. Imaging of beta-cell mass and function. J Nucl Med 2010;51(7):1001-4
   Google Scholar
• Blomberg BA, Codreanu I, Cheng G, et al. Beta-cell imaging: call for evidence-based and scientific approach. Mol Imaging Biol 2013;15(2):123-30
   Google Scholar
• Freeby M, Goland R, Ichise M, et al. VMAT2 quantitation by PET as a biomarker for beta-cell mass in health and disease. Diabetes Obes Metab 2008;10(Suppl 4):98-108
   Google Scholar
• Le Quan Sang KH, Arnoux JB, Mamoune A, et al. Successful treatment of congenital hyperinsulinism with long-acting release octreotide. Eur J Endocrinol 2012;166(2):333-9
   Web of Science ®Google Scholar
• Gabriel M, Decristoforo C, Kendler D, et al. 68Ga-DOTA-Tyr3-octreotide PET in neuroendocrine tumors: comparison with somatostatin receptor scintigraphy and CT. J Nucl Med 2007;48(4):508-18
   PubMed Web of Science ®Google Scholar
• Modan-Moses D, Koren I, Mazor-Aronovitch K, et al. Treatment of congenital hyperinsulinism with lanreotide acetate (Somatuline Autogel). J Clin Endocrinol Metab 2011;96(8):2312-17
   Google Scholar
• Dutta S, Venkataseshan S, Bal C, et al. Novel use of somatostatin receptor scintigraphy in localization of focal congenital hyperinsulinism: promising but fallible. J Pediatr Endocrinol Metab 2009;22(10):965-9
   Google Scholar
• Chandran S, Peng FY, Rajadurai VS, et al. Paternally inherited ABCC8 mutation causing diffuse congenital hyperinsulinism. Endocrinol Diabetes Metab Case Rep 2013;2013:130041
   Google Scholar
• von Rohden L, Mohnike K, Mau H, et al. Visualization of the focus in congenital hyperinsulinism by intraoperative sonography. Semin Pediatr Surg 2011;20(1):28-31
   Web of Science ®Google Scholar
• von Rohden L, Mohnike K, Mau H, et al. Intraoperative sonography: a technique for localizing focal forms of congenital hyperinsulinism in the pancreas. Ultraschall Med 2011;32(1):74-80
   Google Scholar
• Service FJ, McMahon MM, O’Brien PC, Ballard DJ. Functioning insulinoma--incidence, recurrence, and long-term survival of patients: a 60-year study. Mayo Clin Proc 1991;66(7):711-19
   PubMed Web of Science ®Google Scholar
• Peranteau WH, Palladino AA, Bhatti TR, et al. The surgical management of insulinomas in children. J Pediatr Surg 2013;48(12):2517-24
   Google Scholar
• Padidela RN, Fiest M, Arya VB, et al. Insulinoma in childhood: Clinical, radiological, molecular and histology aspects of 9 patients. Eur J Endocrinol 2014;170(5):741-7
   Google Scholar
• Kauhanen S, Seppanen M, Minn H, et al. Fluorine-18-L-dihydroxyphenylalanine (18F-DOPA) positron emission tomography as a tool to localize an insulinoma or beta-cell hyperplasia in adult patients. J Clin Endocrinol Metab 2007;92(4):1237-44
   Google Scholar
• Tessonnier L, Sebag F, Ghander C, et al. Limited value of 18F-F-DOPA PET to localize pancreatic insulin-secreting tumors in adults with hyperinsulinemic hypoglycemia. J Clin Endocrinol Metab 2010;95(1):303-7
   Google Scholar
• Rufini V, Calcagni ML, Baum RP. Imaging of neuroendocrine tumors. Semin Nucl Med 2006;36(3):228-47
   PubMed Web of Science ®Google Scholar